News | Proton Therapy | June 12, 2023

Advancements in precise form of radiotherapy have roots at Massachusetts General Hospital 

Advancements in precise form of radiotherapy have roots at Massachusetts General Hospital

The proton therapy machine located in the Gordon-Browne Proton Therapy Center. Image courtesy of Massachusetts General Hospital


June 12, 2023 — As one of the first hospitals in the world to establish a proton radiotherapy program to treat cancer, Massachusetts General Hospital (MGH) and the Mass General Cancer Center have been pioneers in using and improving proton therapy for treating both benign and malignant tumors effectively while delivering a lower dose of radiation to tissue surrounding the target site. Researchers at MGH have led and continue to lead studies that are defining the best use of proton therapy, which is now being offered at 106 centers worldwide. 

In a Review article published in The Lancet Oncology, Susu Yan, PhD, and Thomas Bortfeld, PhD, from the Biophysics Division of MGH’s Department of Radiation Oncology, and co-authors describe the evolution of proton therapy and its benefits to patients and society. 

While many new centers have begun providing proton radiotherapy, demand continues to outpace supply and there are critical gaps in access to care—currently, there are no centers in the African continent and only one center in development in South America. In their review article, the authors describe several developments that could help make care more accessible, including decreasing the size of the necessary machinery to fit into a conventional treatment room and improving the efficiency of treatment. They also describe some of the advancements in proton therapy that have helped improve the lives of patients, including advancements made at Mass General Cancer Center. 

“Research and development over the past few decades have transformed proton therapy from an extremely rare treatment method to a more common one, although still quite rare,” the authors wrote. “Combining the technological advances with efforts to engage hospitals, academia, industry, regulatory bodies, and funding agencies can make the global democratization of proton therapy a reality.” 

For more information: https://www.massgeneralbrigham.org/ 


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now